Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT03038048

Completed

30g vs 33g Needle for Intravitreal Injections

Diabetic Macular Edema | Retinal Vein Occlusion | Age Related Macular Degeneration
NCT00600028

Completed

Treatment of Chronic Cough in Idiopathic Pulmonary Fibrosis With Thalidomide

Cough | Idiopathic Pulmonary Fibrosis
NCT02976012

Unknown

Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH (LASERLESS)

Proliferative Diabetic Retinopathy
NCT00779558

Completed

Heparin and the Reduction of Thrombosis (HART) Trial

Thrombosis
NCT01691495

Completed

ARIXTRA® Adherence in SVT Patients.

Thrombosis, Venous
NCT00252239

Terminated

Study of Tenecteplase (TNK) in Acute Ischemic Stroke (TNK-S2B)

Stroke
NCT00675441

Terminated

Lenalidomide (Revlimid®) as Second Line Therapy in Patients With Chronic Graft-Vs-Host Disease (GVHD)

Graft-versus-Host Disease
NCT01924624

Unknown

Adjuvant Therapy With Thalidomide After Curative Resection of Hepatocellular Carcinoma

Recurrence | Hepatocellular Carcinoma
NCT01640639

Unknown

THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure (THUNDER)

Congestive Heart Failure
NCT00945906

Completed

An Open Enrollment Study of Factor XIII Concentrate in Subjects With Congenital Factor XIII Deficiency

Factor XIII Deficiency
NCT00713518

Completed

Phase II Open Label Multicenter Study For Age Related Macular Degeneration Comparing PF-04523655 Versus Lucentis In The Treatment Of Subjects With CNV (MONET Study). (MONET)

Age Related Macular Degeneration
NCT01555658

Unknown

Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial (BILLION)

Coronary Artery Disease
NCT00305552

Completed

SARCOTHAL. Thalidomide in Skin Sarcoidosis

Sarcoidosis
NCT00921531

Unknown

Adjuvant Therapy With Thalidomide for Chemoembolization in Advanced Hepatocellular Carcinoma

Hepatocellular Carcinoma
NCT00003894

Completed

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

Unspecified Childhood Solid Tumor, Protocol Specific | Unspecified Adult Solid Tumor, Protocol Specific | Graft Versus Host Disease
NCT00284505

Completed

Use of Thalidomide in Patients With Arachnoiditis

Arachnoiditis
NCT00469703

Terminated

Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis

Chronic Pancreatitis
NCT00455910

Completed

Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200

Myelodysplastic Syndromes
NCT00002157

Completed

Compassionate Use Study of Two Dose Levels of Thalidomide in Adults With HIV Wasting Syndrome

HIV Infections | HIV Wasting Syndrome
NCT00050843

Completed

A Study to Access the Safety/Efficacy of Thalidomide in the Treatment of Anemia in Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes
NCT07116577

Not yet recruiting

Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC

mCRC
NCT06373133

Not yet recruiting

SHR-8068 Combined With Adbelizumab and BP102 in the Treatment of Advanced Colorectal Cancer

Colorectal Cancer
NCT04475835

Recruiting

Safety and Efficacy of Bivalirudin During Short-term Intervention of Non-infarction Related Artery After PPCI of STEMI

STEMI With Multivessel Coronary Disease
NCT01996865

Completed

Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. (MAGNIFY)

Lymphoma, Non-Hodgkin
NCT00848328

Terminated

Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma

Lymphoma
NCT04088292

Active, not recruiting

Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism (STRATIFY)

Pulmonary Embolism
NCT01472562

Completed

Lenalidomide Plus Rituxan for Untreated Mantle Cell Lymphoma

Mantle Cell Lymphoma
NCT04964089

Completed

A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) (DAYLIGHT)

Wet Age-related Macular Degeneration
NCT03558724

Terminated

Fluorescence Endoscopy of Esophageal Carcinoma (ORCA)

Esophageal Cancer
NCT04989699

Completed

Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration

Neovascular Age-Related Macular Degeneration
NCT02207712

Terminated

Noctura400 Treatment for Diabetic Retinopathy (CANDLE) (CANDLE)

Diabetic Macular Oedema
NCT04137120

Completed

Study to Gather Information on the Safety and Use of Aflibercept Injections Into the Eye for the Treatment of Eye Disorders in Mexican Routine Clinical Practice (MAIA)

Retinal Disease
NCT02631577

Completed

A Study Evaluating the Safety and Efficacy of Atezolizumab in Combination With Obinutuzumab Plus Lenalidomide in Patients With Relapsed or Refractory Follicular Lymphoma

Lymphoma, Follicular
NCT05265676

Completed

Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects

Healthy
NCT02303184

Completed

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO (TANZANITE)

Macular Edema | Retinal Vein Occlusion
NCT01956695

Completed

Efficacy of Lenalidomide With Rituximab in Refractory or Relapse of Primary Central Nervous System Lymphoma (REVRI)

Lymphoma | Relapse
NCT02484690

Completed

A Proof-of-Concept Study of Faricimab (RO6867461) in Participants With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (AMD) (AVENUE)

Choroidal Neovascularization
NCT04402762

Completed

Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®

Enoxaparin
NCT01788189

Completed

Lenalidomide, MTX, Ara-C and Rituximab in Relapsed Aggressive B-cell Lymphomas (LeMLAR)

B-cell Lymphoma
NCT01580969

Completed

Repeat Radiation, Minocycline and Bevacizumab in Patients With Recurrent Glioma (RAMBO)

Recurrent Glioma
NCT01846273

Completed

Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT) (EVEREST II)

Age-related Macular Degeneration | Polypoidal Choroidal Vasculopathy
NCT03970213

Unknown

Intravenous Tranexamic Acid During Rhytidectomy

Bleeding | Bruising Face | Swelling Lips & Face
NCT00038181

Completed

Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer

Prostate Cancer
NCT00320398

Completed

Total Hip Replacement Study Of GSK576428 (Fondaparinux Sodium)

Thrombosis, Venous
NCT03426982

Unknown

Comparision Between Activated Partial Thromboplastin Time Versus Anti-Xa Activity in Heparin Monitoring (CATCH)

Myocardial Infarction | Stroke | Bleeding | Venous Thromboembolism
NCT03341494

Unknown

EGFR Mutation Positive NSCLC Patients With Gefitinib and Thalidomide

Chemotherapy Effect | NSCLC Stage IV
NCT01254578

Completed

Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers

Recurrent Adult Burkitt Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenstrom Macroglobulinemia | Adult Acute Myeloid Leukemia in Remission
NCT00423930

Completed

Cisplatin, Bevacizumab, and Intensity-Modulated Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer
NCT00026533

Completed

Thalidomide in Treating Patients With Thyroid Cancer

Head and Neck Cancer
NCT00004070

Completed

Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer

Head and Neck Cancer

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations